🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

📢 PSA: Primary care doctors and internists: ‼️Please 🛑 telling patients “it’s just fatty liver” Common, yes. But not benign! ✅ Take 🍺🍸history, perform brief intervention ✅ Manage metabolic risk factors 🧐Fibrosis (FIB-4…) ☎️ Your friendly hepatologist if you need help!

In personal news… 🫶🏼

🔥🔥🔥

⏰ Pub Alert! 📖 Our study explores how diverse educational resources—from podcasts to blogs to social media—shape how residents think, question, & practice medicine. #MedEd Shreya P. Trivedi MD, MHPE Thanks to all my General Internal Medicine residents who participated! pmc.ncbi.nlm.nih.gov/articles/PMC12…

So happy to win 1st place prize for Quality Improvement at the Montefiore Health System research symposium tonight ! Brett E Fortune MD and I have worked hard on this endeavor, and much more to come! Next stop... #ADA2025 American Diabetes Association

🧬New 📋 Veeral Ajmera Journal of Hepatology: In MASLD, inherited genetic risk drives age-associated fibrosis. ⬆️ LSMs after 40y in high-risk genotypes 🧪 PNPLA3 genotyping may improve risk stratification 📈 Supports personalized medicine 🔗 doi.org/10.1016/j.jhep… Rohit Loomba UCSD Gastroenterology

Maybe it is time to incorporate genetic testing in high risk MASLD? Read everything here 👇👇👇

YOUR Big Red Lacrosse ARE THE 2025 NCAA DIVISION I NATIONAL CHAMPIONS! 🔴⚪🥍

Metabolic dysfunction-associated steatohepatitis (MASH) drives rising morbidity and mortality, yet remains underdiagnosed. A new Health Policy paper by Jeffrey V. Lazarus and colleagues calls for community-based diagnostics: shorturl.at/a0COQ #LiverTwitter #SLDthinktank

The Global Think-tank on Steatotic Liver Disease is proud to announce two groundbreaking publications: The People-First Liver Charter, in Nature Medicine nature.com/articles/s4159… 2. A call for doubling the MASH diagnostic rate: thelancet.com/journals/lanep… #SLDthinktank #LiverTwitter

The Lancet Reg Health-Europe Doubling the MASH diagnostic rate was hotly debated at the #SLDthinktank. How do we best do this by 2027? thelancet.com/journals/lanep… The Lancet Reg Health-Europe #LiverTwitter

Please disregard the medical opinion of any physician claiming doctors profit off keeping you sick and then in their next breath, try to sell you their own unregulated, non-evidence based supplements.

Equally humbled and excited to be a part of the landmark People-First Liver Charter published today in nature !!! A critical step forward in putting those with lived experience at the center of how we discuss & manage chronic liver disease. nature.com/articles/s4159…

We renamed a disease—not for science, but for people. 🩺 Proud to co-author the People-First Liver Charter alongside greats in Nature Portfolio 🔗 nature.com/articles/s4159… Words can heal. Let’s end stigma in MASLD/MASH—across every specialty. 🌍💬

🚨 New in NEJM : Orforglipron, a once-daily oral GLP‑1, led to ~2% A1c drop & ~16 lb weight loss in T2D (ACHIEVE-1 trial). A non-peptide, no-injection option with classic GLP-1 GI profile. Big step for access & adherence! 🔗nejm.org/doi/full/10.10…

A stepwise, noninvasive strategy with FIB-4 followed by VCTE accurately identifies fibrosis risk in people with suspected #MetALD, helping to catch more cases and reduce missed diagnoses. journals.lww.com/hepcomm/Fullte…

Really important !!! As endocrinology and obesity care providers we have to team up with our GI/Hepatology colleagues to help with metabolic management.

In less than a year Dr. Brett E Fortune MD has helped me advance my research career and helped me create a name for myself in the MASLD space which is my absolute passion. He is a testament to the power of what mentorship and sponsorship can do!!!!

Melina Manolas, MD, MPH Oh wow 🥹 thank you for the kind words Melina Manolas, MD, MPH but it was all you, i was just around if you needed anything 😃 good luck on next chapter with Weill Department of Medicine and Weill Cornell Medicine ! Its a great team!! We are excited to have a hepato-endocrinologist champion like Scott Isaacs

Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in Focus: Why Every Diabetes Provider Needs to Be a Liver Health Champion in 2025 opmed.doximity.com/articles/metab… via Doximity